Acella Pharmaceuticals Recalls Doxycycline Hyclate Tablets Over Dissolution Issue
Acella Pharmaceuticals recalled 4,680 bottles of Doxycycline Hyclate Tablets on September 29, 2025. The recall follows failed dissolution specifications, which can affect medication efficacy. This recall includes 500-count bottles distributed nationwide in the USA.
Product Details
The recalled product is Doxycycline Hyclate Tablets, USP 100 mg, in 500-count bottles. The lot number is P24ZLK1, with an expiration date of May 31, 2027.
The Hazard
The recall stems from stability testing that revealed the product did not meet dissolution specifications. This failure may compromise the effectiveness of the medication.
Reported Incidents
There have been no reported injuries or adverse events associated with this recall. The risk remains high due to potential ineffectiveness of the medication.
What to Do
Consumers and healthcare providers should stop using the recalled product immediately. Contact Acella Pharmaceuticals or your healthcare provider for guidance on next steps.
Contact Information
For more information, contact Acella Pharmaceuticals, LLC at their customer service line or visit their website.